Cognition Therapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -68 | -61 | -61 | |
EBITDA | -3,929 | -4,497 | -3,277 | -4,869 |
EBIT | -4,565 | -3,338 | -4,930 | |
Net Income | -3,932 | -4,570 | -3,343 | -4,930 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,073 | -5,542 | -3,437 | -5,651 |
Cash | 34,012 | 31,130 | 37,000 | 39,823 |
Basic Shares | 90,624 | 89,191 | 88,904 | 77,951 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -228 | -266 | -252 | -235 |
EBITDA | -23,246 | -33,680 | -25,509 | -21,134 |
EBIT | -23,474 | -33,946 | -25,761 | -21,369 |
Net Income | -23,487 | -33,971 | -25,788 | 757 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -13,158 | |||
Free Cash Flow | -24,588 | -28,478 | -16,165 | -18,704 |
Cash | 36,810 | 25,009 | 29,922 | 41,562 |
Basic Shares | 72,766 | 39,730 | 30,029 | 28,991 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.04 |
2026-03-31 | -$0.05 |
2025-12-31 | -$0.02 |
2025-09-30 | -$0.06 |